Thyroid eye disease following administration of the BNT162B2 COVID-19 vaccine

被引:2
|
作者
Fujita, H. [1 ]
Makino, S. [2 ,3 ]
Hasegawa, T.
Saima, Y. [4 ]
Tanaka, Y. [1 ]
Nagashima, S. [5 ]
Kakehashi, A. [1 ]
Kaburaki, T. [1 ,6 ]
机构
[1] Jichi Med Univ, Dept Ophthalmol, Saitama Med Ctr, Saitama, Saitama, Japan
[2] Inoda Eye Clin, Nasushiobara, Tochigi, Japan
[3] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan
[4] Nihon Univ, Div Ophthalmol, Itabashi Hosp, Itabashi Ku, Tokyo, Japan
[5] Jichi Med Univ, Dept Endocrinol & Metab, Saitama Med Ctr, Saitama, Saitama, Japan
[6] Jichi Med Univ, Dept Ophthalmol, Saitama Med Ctr, Saitama, Saitama 3308503, Japan
关键词
GRAVES-DISEASE; SARS-COV-2;
D O I
10.1093/qjmed/hcac265
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:130 / 132
页数:3
相关论文
共 50 条
  • [11] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Dagan, Noa
    Barda, Noam
    Biron-Shental, Tal
    Makov-Assif, Maya
    Key, Calanit
    Kohane, Isaac S.
    Hernan, Miguel A.
    Lipsitch, Marc
    Hernandez-Diaz, Sonia
    Reis, Ben Y.
    Balicer, Ran D.
    NATURE MEDICINE, 2021, 27 (10) : 1693 - +
  • [12] Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine
    Roca, B.
    Rambla, M.
    Roca, M.
    JOURNAL OF POSTGRADUATE MEDICINE, 2021, 67 (03) : 180 - 181
  • [13] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Noa Dagan
    Noam Barda
    Tal Biron-Shental
    Maya Makov-Assif
    Calanit Key
    Isaac S. Kohane
    Miguel A. Hernán
    Marc Lipsitch
    Sonia Hernandez-Diaz
    Ben Y. Reis
    Ran D. Balicer
    Nature Medicine, 2021, 27 : 1693 - 1695
  • [14] BNT162b2 Vaccine Booster and Mortality Due to Covid-19
    Arbel, Ronen
    Hammerman, Ariel
    Sergienko, Ruslan
    Friger, Michael
    Peretz, Alon
    Netzer, Doron
    Yaron, Shlomit
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26): : 2413 - 2420
  • [15] BNT162b2 mRNA COVID-19 Vaccine: First Approval
    Lamb, Yvette N.
    DRUGS, 2021, 81 (04) : 495 - 501
  • [16] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine
    Lopez-Valle, Alba
    Falkenhain-Lopez, Daniel
    Arranz, Celia R.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (07) : 891 - 892
  • [17] Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds
    Ribak, Yaarit
    Rubin, Limor
    Talmon, Aviv
    Dranitzki, Zvi
    Shamriz, Oded
    Hershkowitz, Isca
    Tal, Yuval
    Hershko, Alon Y.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [18] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Polack, Fernando P.
    Thomas, Stephen J.
    Kitchin, Nicholas
    Absalon, Judith
    Gurtman, Alejandra
    Lockhart, Stephen
    Perez, John L.
    Perez Marc, Gonzalo
    Moreira, Edson D.
    Zerbini, Cristiano
    Bailey, Ruth
    Swanson, Kena A.
    Roychoudhury, Satrajit
    Koury, Kenneth
    Li, Ping
    Kalina, Warren V.
    Cooper, David
    Frenck, Robert W., Jr.
    Hammitt, Laura L.
    Tureci, Ozlem
    Nell, Haylene
    Schaefer, Axel
    Unal, Serhat
    Tresnan, Dina B.
    Mather, Susan
    Dormitzer, Philip R.
    Sahin, Ugur
    Jansen, Kathrin U.
    Gruber, William C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27): : 2603 - 2615
  • [19] Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine in Patients with Cardiovascular Disease
    Naruse, Hiroyuki
    Ito, Hiroyasu
    Izawa, Hideo
    Sarai, Masayoshi
    Ishii, Junnichi
    Sakaguchi, Eirin
    Murakami, Reiko
    Ando, Tatsuya
    Fujigaki, Hidetsugu
    Saito, Kuniaki
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [20] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Wang, Xiang
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1577 - 1578